Algert Global’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Buy
131,400
+69,040
+111% +$1.39M 0.03% 770
2026
Q1
$1.22M Sell
62,360
-62,770
-50% -$1.54M 0.02% 821
2025
Q4
$3.35M Sell
125,130
-267,772
-68% -$6.9M 0.05% 569
2025
Q3
$10.5M Buy
392,902
+268,612
+216% +$6.94M 0.18% 171
2025
Q2
$2.85M Buy
124,290
+106,990
+618% +$2.65M 0.06% 516
2025
Q1
$502K Buy
+17,300
New +$553K 0.01% 913
2024
Q4
Sell
-66,285
Closed -$3.22M 1168
2024
Q3
$3.22M Buy
+66,285
New +$2.91M 0.09% 408
2024
Q1
Sell
-16,820
Closed -$1.04M 1071
2023
Q4
$1.04M Hold
16,820
0.04% 607
2023
Q3
$774K Sell
16,820
-34,560
-67% -$1.89M 0.04% 625
2023
Q2
$2.95M Buy
51,380
+21,060
+69% +$934K 0.13% 251
2023
Q1
$1.14M Buy
30,320
+21,667
+250% +$710K 0.05% 595
2022
Q4
$242K Sell
8,653
-26,870
-76% -$780K 0.01% 971
2022
Q3
$998K Buy
35,523
+4,790
+16% +$156K 0.06% 545
2022
Q2
$1.07M Buy
30,733
+16,490
+116% +$588K 0.08% 439
2022
Q1
$511K Buy
+14,243
New +$404K 0.03% 804
2016
Q4
Sell
-31,761
Closed -$603K 327
2016
Q3
$603K Buy
+31,761
New +$576K 0.17% 216

Other funds holding AMPH

Algert Global's AMPH Position: Q2 2026 in Review

Algert Global increased its Amphastar Pharmaceuticals (AMPH) stake by 111% in Q2 2026, buying an estimated $1.39M and bringing the position to 131,400 shares worth $2.65M. The position accounts for 0.03% of the portfolio, ranked #770.

Algert Global first reported a position in AMPH in Q3 2016 and has held it in 16 quarters since. The position peaked at $10.5M in Q3 2025. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Algert Global held 131,400 shares of Amphastar Pharmaceuticals worth $2.65M as of Q2 2026.
  • Algert Global bought 69,040 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.39M.
  • Amphastar Pharmaceuticals made up 0.03% of Algert Global's portfolio in Q2 2026, its #770 holding.
  • Algert Global first reported a position in Amphastar Pharmaceuticals in Q3 2016 and has held it in 16 quarters since.
  • Algert Global's Amphastar Pharmaceuticals position peaked at $10.5M in Q3 2025.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.